SilverArc
Startup rounds since 2018 with a SilverArc investor on the board, and the firm's own fund filings.
Raises
11
since 2018
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Ventyx Biosciences, Inc.$27M
- Lila Biologics, Inc.$9.54M
- ADARx Pharmaceuticals, Inc.$200M
- ADARx Pharmaceuticals, Inc.$46M
- Ventyx Biosciences, Inc.$51M
- ADARx Pharmaceuticals, Inc.$75M
- Ventyx Biosciences, Inc.$114M
- ADARx Pharmaceuticals, Inc.$15.5M
- Janux Therapeutics, Inc.$125M
- ADARx Pharmaceuticals, Inc.$6M
- TP Therapeutics, Inc.$80M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2024 | 1 | — |
| 2023 | 3 | — |
| 2021 | 5 | — |
| 2020 | 1 | — |
| 2018 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| SilverArc Private Fund I, LP | 29 Apr 2026 | Open-ended | $22M |
Listed because a SilverArc fund's filing names a director of each company. A name match is not a verified identity.